内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Kardigan, Inc.

KARD · Nasdaq · CIK 0002123613 · Healthcare · Biotechnology

内部人信号

71.0 / 100

3 位买方 · 3 条买入交易行 · $90.0M 买入总额

为什么有这个信号？

买方广度中等
买入规模较强
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+21.0 / 35
买入规模+24.6 / 25
角色+14.0 / 20
近期性+1.4 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
  • ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
BERNS PAUL LDirector,TenPercentOwner
○○●
ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XIII, L.P.; ARCH Venture Partners XIII, LLC; Burow Kristina; CRANDELL KEITH; GILLIS STEVEN; NELSEN ROBERTDirector,TenPercentOwner
○●
Edelberg JayChief Medical Officer
○○
HRTG CIF 2024, L.P.; HRTG GPE, LLC; HRTG PV, L.P.; Johnson Keith Bryon; Kelly Kevin AnthonyTenPercentOwner
●
HRTG GPE, LLC; HRTG PV, L.P.; Johnson Keith Bryon; Kelly Kevin Anthony; SCHF CIF 2024, L.P.TenPercentOwner
○
Pasternak AndyChief Strategy Officer
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方3
买入集中度56%最大买方： HRTG CIF 2024, L.P.; HRTG GPE, LLC; HRTG PV, L.P.; Johnson Keith Bryon; Kelly Kevin Anthony · $50.0M
聚集买入 · 15天3 insiders峰值活动： 2026-06-22–2026-06-22

Roles in the peak window: Director,TenPercentOwner, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

71.0 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 71.1
  2. 71.1
  3. 71.0
  4. 71.0
  5. 71.0

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

3买入
0卖出
20其他 Form 4 交易行
16SEC 申报 · 365天
买入3 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他20 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-21.5%
3M
-37.7%
6M
—
12M
—

波动率与流动性

波动率
70.7%
Beta
—
平均每日成交额
USD 7.3M

估值

市值
USD 1.4B
P/E
—

基本面

利润率
—
ROE
—
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-07 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
4,445,126
上期报告
2,568,799
日均成交量
1,179,559
回补天数
3.8

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-06-22HRTG CIF 2024, L.P.; HRTG GPE, LLC; HRTG PV, L.P.; Johnson Keith Bryon; Kelly Kevin Anthony买入 (P)Common Stock3,125,000USD 16.00USD 50,000,000SEC 申报 ↗
2026-06-22BERNS PAUL L买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗
2026-06-22ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XIII, L.P.; ARCH Venture Partners XIII, LLC; Burow Kristina; CRANDELL KEITH; GILLIS STEVEN; NELSEN ROBERT买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗

Form 4 申报证据

23 transaction lines in the latest 365-day window; 23 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-06-22HRTG CIF 2024, L.P.; HRTG GPE, LLC; HRTG PV, L.P.; Johnson Keith Bryon; Kelly Kevin Anthony买入 (P)Common Stock3,125,000USD 16.00USD 50,000,000SEC 申报 ↗
2026-06-22BERNS PAUL L买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗
2026-06-22ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XIII, L.P.; ARCH Venture Partners XIII, LLC; Burow Kristina; CRANDELL KEITH; GILLIS STEVEN; NELSEN ROBERT买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗
展开近期 Form 4 证据 (18 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-06-22HRTG CIF 2024, L.P.; HRTG GPE, LLC; HRTG PV, L.P.; Johnson Keith Bryon; Kelly Kevin Anthony买入 (P)Common Stock3,125,000USD 16.00USD 50,000,000SEC 申报 ↗
2026-06-22BERNS PAUL L买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗
2026-06-22ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XIII, L.P.; ARCH Venture Partners XIII, LLC; Burow Kristina; CRANDELL KEITH; GILLIS STEVEN; NELSEN ROBERT买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗
2026-06-17EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Capital Solutions Holdings LP奖励／授予 (A)Common Stock20,706USD 0.00USD 0SEC 申报 ↗
2026-06-17Walbert Timothy P奖励／授予 (A)Common Stock20,706USD 0.00USD 0SEC 申报 ↗
2026-06-17Popovits Kimberly J奖励／授予 (A)Common Stock20,706USD 0.00USD 0SEC 申报 ↗
2026-06-17Pasternak Andy奖励／授予 (A)Common Stock79,640USD 0.00USD 0SEC 申报 ↗
2026-06-17Moriarty John B奖励／授予 (A)Common Stock47,784USD 0.00USD 0SEC 申报 ↗
2026-06-17Meeker David P奖励／授予 (A)Common Stock20,706USD 0.00USD 0SEC 申报 ↗
2026-06-17Jahn Brianne奖励／授予 (A)Common Stock79,640USD 0.00USD 0SEC 申报 ↗
2026-06-17HRTG GPE, LLC; HRTG PV, L.P.; Johnson Keith Bryon; Kelly Kevin Anthony; SCHF CIF 2024, L.P.C (C)Common Stock13,792,034USD —USD —SEC 申报 ↗
2026-06-17Giordano Douglas E.奖励／授予 (A)Common Stock20,706USD 0.00USD 0SEC 申报 ↗
2026-06-17GIANAKAKOS ANASTASIOSC (C)Common Stock568,395USD —USD —SEC 申报 ↗
2026-06-17Edelberg JayC (C)Common Stock97,587USD —USD —SEC 申报 ↗
2026-06-17Edelberg Jay奖励／授予 (A)Common Stock47,784USD 0.00USD 0SEC 申报 ↗
2026-06-17BERNS PAUL LC (C)Common Stock13,792,035USD —USD —SEC 申报 ↗
2026-06-17BERNS PAUL L奖励／授予 (A)Common Stock20,706USD 0.00USD 0SEC 申报 ↗
2026-06-17ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XIII, L.P.; ARCH Venture Partners XIII, LLC; Burow Kristina; CRANDELL KEITH; GILLIS STEVEN; NELSEN ROBERTC (C)Common Stock13,792,035USD —USD —SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码KARD
CIK0002123613
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史23 transaction lines from 2026-06-17 to 2026-06-22
3 P purchase lines · 0 S sale lines · 20 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.